Mereo BioPharma Group
Tracked across 1 events · 7 articles · First seen Apr 01, 2026 · Last active May 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Mereo BioPharma Group is facing a securities class action lawsuit for allegedly disseminating false and misleading statements regarding its Phase 3 clinical trials, causing investors to purchase its ADSs at inflated prices.
Apr 01, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Mereo BioPharma Group live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard